Biofunctional Layered Double Hydroxide Nanohybrids for Cancer Therapy

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Layered double hydroxides (LDHs) are 2D nanomaterials with excellent biocompatibility and drug loading capabilities.
• The intercalation of DNA into LDHs has paved the way for developing novel nanohybrids for biomedical applications.
• LDHs hybridized with therapeutic agents show significant promise in cancer imaging and targeted therapy.

Purpose of the Study:

• To review recent advancements in the preparation of LDH nanohybrids.
• To explore the application of LDH nanohybrids in various cancer therapeutic strategies.
• To highlight the potential of LDHs in targeted cancer treatment.

Main Methods:

• Literature review of recent research on LDH nanohybrids.
• Analysis of preparation techniques for LDH-based nanostructures.
• Synthesis and characterization of LDH-drug conjugates.

Main Results:

• LDH nanohybrids have been successfully developed for various drug delivery systems.
• These nanohybrids demonstrate efficacy in gene therapy, chemotherapy, immunotherapy, and combination therapy for cancer.
• Targeting functions of LDH nanohybrids enhance their role in cancer imaging and treatment.

Conclusions:

• LDH nanohybrids represent a promising platform for developing innovative cancer therapeutics.
• Further research into LDH nanohybrid preparation and application will advance targeted cancer treatment strategies.
• The unique properties of LDHs make them valuable for multifaceted cancer imaging and therapy.